The use of povidone iodine in exit site care for patients undergoing continuous peritoneal dialysis (CAPD).
Exit site infection is a major risk factor for the development of peritonitis in continuous ambulatory peritoneal dialysis. The frequency of infection can be reduced by scrupulous exit site care with or without topical antiseptics. A randomized trial was performed of 149 catheters in 130 patients to assess any additional benefits conferred by the use of povidine iodine dry powder spray at dressing changes over an existing strict protocol of exit care. Exit infections occurred in 14 (18%) of 77 patients using spray and in 15 (21%) of 72 patients not using spray. The risk of peritonitis was also similar in each group. The proportion of infections caused by Staphylococcus aureus was reduced in the spray group, but those caused by Pseudomonas aeruginosa were increased. Rash occurred in 6% of those using the spray. The use of the spray did not therefore seem justified.
Wilson
A P
AP
Department of Clinical Microbiology, University College London Hospitals, UK.
Lewis
C
C
O'Sullivan
H
H
Shetty
N
N
Neild
G H
GH
Mansell
M
M
D000368:Aged; D000369:Aged, 80 and over; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002404:Catheterization / Q000009:adverse effects / Q000379:methods; D005260:Female; D006801:Humans; D017053:Infection Control / Q000379:methods; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects / Q000379:methods*; D011206:Povidone-Iodine / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000517:prevention & control; D013203:Staphylococcal Infections / Q000517:prevention & control
D000891:Anti-Infective Agents, Local; D011206:Povidone-Iodine